Send to a Friend Font Size: Increase Decrease

RGT and SBEV Related Headlines

Jul 7, 2026 07:38AM Splash Beverage licenses cannabinoid epilepsy therapy CannEpil globally
Jul 7, 2026 06:13AM SPLASH BEVERAGE GROUP ACQUIRES EXCLUSIVE GLOBAL RIGHTS TO CANNEPIL®, AN EPILEPSY THERAPY WITH ESTABLISHED EUROPEAN PATIENT ACCESS, FDA ENGAGEMENT AND U.S. DEVELOPMENT POTENTIAL

RGT and SBEV Related Press Releases

Jul 7, 2026 06:13AM SPLASH BEVERAGE GROUP ACQUIRES EXCLUSIVE GLOBAL RIGHTS TO CANNEPIL®, AN EPILEPSY THERAPY WITH ESTABLISHED EUROPEAN PATIENT ACCESS, FDA ENGAGEMENT AND U.S. DEVELOPMENT POTENTIAL

RGT and SBEV Related SEC Filings